- RecruitingPHASE4
Real-World Effectiveness and Safety of Pegcetacoplan in Patients With C3G or IC-MPG: A Multi-Country Study
This study looks at how well a medicine called pegcetacoplan works and if it's safe for people in the UK with rare kidney diseases like C3G or IC-MPGN. It uses real-life information from patients to help doctors make better decisions about treatment.
For: C3 Glomerulopathy (C3G) · Immune Complex Membranoproliferative Glomerulonephritis (IC-MPGN)Australia · Austria · Belgium - Active not recruitingPHASE3
An Open-Label, Nonrandomized, Multicenter Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan in Participants With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis
This study looks at the long-term effects of a medicine called pegcetacoplan for kidney conditions like C3 Glomerulopathy (C3G) and IC-MPGN. It's for people who were in a previous study and seemed to benefit from the treatment.
For: C3G · IC-MPGN · C3 GlomerulopathyUnited States · Argentina · Australia - Recruiting
A Real World Effectiveness Study of Pegcetacoplan in Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
This study looks at how a new PNH treatment, pegcetacoplan, works in real life. It aims to see how effective and safe it is for patients with Paroxysmal Nocturnal Hemoglobinuria over several years.
For: Paroxysmal Nocturnal HemoglobinuriaAustralia · Belgium · Canada - RecruitingPHASE2
A Study of Pegcetacoplan in Pediatric Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)
This study is for young people aged 12-17 with a blood condition called Paroxysmal Nocturnal Hemoglobinuria (PNH). It's testing a new medicine, pegcetacoplan, to see if it's safe and effective, and how it works in the body.
For: Paroxysmal Nocturnal Hemoglobinuria (PNH) · Paroxysmal HemoglobinuriaUnited States · Czechia · France - Active not recruitingPHASE3
Pegcetacoplan Long Term Safety and Efficacy Extension Study
This study is for people with PNH who have already been in a pegcetacoplan trial. It looks at the long-term safety and how well the treatment works over time. Participants will continue to receive pegcetacoplan.
For: PNHUnited States · Australia · Belgium